Search results
Results from the WOW.Com Content Network
An AstraZeneca executive last week said the company expected a limited impact because its diabetes drug Farxiga will face competition from cheaper generic drugs around three months after the new ...
Dapagliflozin, sold under the brand names Farxiga (US) and Forxiga (EU) among others, is a medication used to treat type 2 diabetes. [ 6 ] [ 7 ] [ 9 ] It is also used to treat adults with heart failure and chronic kidney disease .
Canagliflozin is an anti-diabetic medication used to improve blood sugar control in people with type 2 diabetes. It is a third-line medication to metformin. [ 9] Per the British National Formulary it is also less preferred than a sulfonylurea as of 2019, while the American Diabetes Association and European Association for the Study of Diabetes ...
Medical News Today. Medical News Today is a web-based outlet for medical information and news, targeted at both the general public and physicians. All posted content is available online (>250,000 articles as of January 2014), and the earliest available article dates from May 2003. The website was founded in 2003 by Alastair Hazell and Christian ...
AstraZeneca's blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of heart failure, according to study data released ...
For premium support please call: 800-290-4726 more ways to reach us
SGLT2 inhibitor. SGLT2 inhibitors (also called gliflozins or flozins) are a class of medications that inhibit sodium-glucose transport proteins in the nephron (the functional units of the kidney ), unlike SGLT1 inhibitors that perform a similar function in the intestinal mucosa. The foremost metabolic effect of this is to inhibit reabsorption ...
August 12, 2024 at 7:22 AM. (Reuters) -Ascendis Pharma's said on Monday the U.S. Food & Drug Administration had approved its therapy to treat adult patients with a hormone disorder. Ascendis ...